Patents Represented by Attorney, Agent or Law Firm Hugh Wang
  • Method of eosinophil depletion with antibody to CCR 3 receptor
    Patent number: 6207155
    Abstract: Binding compositions and various methods of use of the binding compositions are provided. In particular, a method is provided which comprises administering an effective amount of the binding composition, alone or in combination with other compounds, to eosinophils, thereby reducing the level of eosinophils in an individual. Preferably, the binding composition is a monoclonal antibody specific for CCR3.
    Type: Grant
    Filed: May 6, 1998
    Date of Patent: March 27, 2001
    Assignee: Schering Corporation
    Inventors: J. Christopher Grimaldi, Maureen C. Howard, Robert L. Coffman